COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
HiiiWAV Fest Overcomes City Budget Deficit to Launch Oakland’s 1st Music and Tech Festival June 8th
HiiiWAV presents HiiiWAV Fest, combining AI & VR tech with Black music in Oakland on June 8th. Event saved by sponsors after city grant delay. Join to support at hiiiwav.org/donate -
COMMUNIQUÉ DE PRESSE
New York Sephardic Jewish Film Festival Honors Reymonde Amsellem, Alexandre Arcady, Stella Levi, & John Turturro; Features Enrico Macias Opening Night Performance
The American Sephardi Federation's 26th New York Sephardic Film Festival opens on June 2 at the Center for Jewish History. Featuring honorees like Alexandre Arcady, Stella Levi, and John Turturro, the festival showcases Sephardic culture through film premieres and special performances -
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Jaguar announces expansion of out-licensing agreement with Magdalena Biosciences for Botanical Drug Candidate targeting schizophrenia market. Company to present at Lytham Partners Spring 2024 Investor Conference -
COMMUNIQUÉ DE PRESSE
JEV Portfolio Company Supercritical and HAMR Energy to Shake Up Methanol Production with Groundbreaking, Government-Backed, Green Partnership
Consortium led by Jericho Energy Ventures Inc. and partners awarded funding for renewable methanol project to reduce costs by 20% with high-pressure green hydrogen production, aiming for commercialization by 2030 -
COMMUNIQUÉ DE PRESSE
Panoramic Health Elevates Kidney Care Innovation With Appointment of Dr. Navdeep Tangri as Senior Advisor for Panoramic Science
Dr. Navdeep Tangri appointed as Senior Advisor for Panoramic Science, advancing kidney care with novel therapies. Panoramic Health's commitment to innovation and patient outcomes highlighted -
-
-
COMMUNIQUÉ DE PRESSE
BOOSTER Precision Components GmbH’s reports results for the first quarter of 2024
BOOSTER Precision Components GmbH reports results for the first quarter of 2024 with a revenue decrease of -8.3% year-on-year. EBITDA declined to EUR 4.5 million in Q1 2024. Measures taken include bond increase and cost-cutting
